Hyperkalemia in a patient with advanced hepatocellular carcinoma probably due to sorafenib: case report.

Sorafenib is an oral tyrosine kinase inhibitor used in the treatment of metastatic hepatocellular carcinoma (HCC). Its common adverse reactions include diarrhea, hand-foot syndrome, rash, cardiac ischemia or infarction, hypertension, elevated serum lipase and hypophosphatemia. A 35-year-old male pat...

Full description

Bibliographic Details

Published in:	Turkiye Klinikleri Journal of Medical Sciences Vol. 32; no. 2; pp. 585 - 588
Main Authors:	Uyeturk, Ummugul, Budakoglu, Burcin, Helvaci, Kaan, Sonmez, Ozlem Uysal, Turker, Ibrahim, Arslan, Ulku Yalcintas, Oksuzoglu, Berna, Zengin, Nurullah
Format:	case study Journal Article
Published:	Turkiye Klinikleri Apr2012
Online Access:	View this record in EBSCOhost